{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:53:48Z","timestamp":1784231628665,"version":"3.55.0"},"reference-count":409,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,30]],"date-time":"2018-03-30T00:00:00Z","timestamp":1522368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004113","name":"Lebanese University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004113","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009841","name":"University of the Pacific","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009841","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.bj.2018.03.004","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T22:56:54Z","timestamp":1525993014000},"page":"63-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":159,"title":["Salivary biomarkers for the diagnosis and\u00a0monitoring of neurological diseases"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7844-7799","authenticated-orcid":false,"given":"Raymond","family":"Farah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayat","family":"Haraty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"Salame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Fares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Ojcius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najwane","family":"Said Sadier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bj.2018.03.004_bib1","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1172\/JCI24761","article-title":"The genetic epidemiology of neurodegenerative disease","volume":"115","author":"Bertram","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bj.2018.03.004_bib2","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1289\/ehp.7571","article-title":"Early environmental origins of neurodegenerative disease in later life","volume":"113","author":"Landrigan","year":"2005","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.bj.2018.03.004_bib3","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/nm1067","article-title":"Molecular pathways to neurodegeneration","volume":"10","author":"Bossy-Wetzel","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.bj.2018.03.004_bib4","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1126\/science.1090349","article-title":"Looking backward to move forward: early detection of neurodegenerative disorders","volume":"302","author":"DeKosky","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bj.2018.03.004_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0733-8619(05)70368-6","article-title":"Complications of lumbar puncture","volume":"16","author":"Evans","year":"1998","journal-title":"Neurol Clin"},{"key":"10.1016\/j.bj.2018.03.004_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.gpb.2015.08.005","article-title":"Urinary biomarkers of brain diseases","volume":"13","author":"An","year":"2015","journal-title":"Genomics Proteom Bioinform"},{"key":"10.1016\/j.bj.2018.03.004_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11010-014-2274-1","article-title":"Patients with multiple sclerosis show increased oxidative stress markers and somatic telomere length shortening","volume":"400","author":"Guan","year":"2015","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.bj.2018.03.004_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/704678","article-title":"Increased DJ-1 in urine exosome of Korean males with Parkinson's disease","author":"Ho","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.bj.2018.03.004_bib9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neulet.2008.02.019","article-title":"Detection of amyloid \u03b2 protein in the urine of Alzheimer's disease patients and healthy individuals","volume":"435","author":"Takata","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bj.2018.03.004_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/10454411950060020501","article-title":"Biochemical composition of human saliva in relation to other mucosal fluids","volume":"6","author":"Schenkels","year":"1995","journal-title":"Crit Rev Oral Biol Med"},{"key":"10.1016\/j.bj.2018.03.004_bib11","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1177\/00220345870660S103","article-title":"The functions of saliva","volume":"66","author":"Mandel","year":"1987","journal-title":"J Dent Res"},{"key":"10.1016\/j.bj.2018.03.004_bib12","series-title":"Clinically oriented anatomy","author":"Moore","year":"2010"},{"key":"10.1016\/j.bj.2018.03.004_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3233\/JAD-2011-110731","article-title":"Salivary tau species are potential biomarkers of Alzheimer's disease","volume":"27","author":"Shi","year":"2011","journal-title":"J Alzheim Dis"},{"key":"10.1016\/j.bj.2018.03.004_bib14","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/j.0022-0337.2001.65.12.tb03492.x","article-title":"A revolution in biomedical assessment: the development of salivary diagnostics","volume":"65","author":"Tabak","year":"2001","journal-title":"J Dent Educ"},{"key":"10.1016\/j.bj.2018.03.004_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1034\/j.1601-0825.2002.1o834.x","article-title":"Saliva as a diagnostic fluid","volume":"8","author":"Streckfus","year":"2002","journal-title":"Oral Dis"},{"key":"10.1016\/j.bj.2018.03.004_bib16","series-title":"Regional neuronal loss in aging and Alzheimer's disease: a brief review","first-page":"307","author":"O'Banion","year":"1994"},{"key":"10.1016\/j.bj.2018.03.004_bib17","first-page":"152","article-title":"Hippocampal neuronal loss in the CA1 and CA3 areas of Alzheimer's disease patients","volume":"24","author":"Padurariu","year":"2012","journal-title":"Psychiatr Danub"},{"key":"10.1016\/j.bj.2018.03.004_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002093-199903000-00001","article-title":"Cerebral amyloid angiopathy in Alzheimer disease is associated with apolipoprotein E4 and cortical neuron loss","volume":"13","author":"Zarow","year":"1999","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.bj.2018.03.004_bib19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1101\/lm.1310209","article-title":"Amyloid beta mediates memory formation","volume":"16","author":"Garcia-Osta","year":"2009","journal-title":"Learn Mem"},{"key":"10.1016\/j.bj.2018.03.004_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.molmed.2007.06.004","article-title":"Amyloid beta as a regulator of lipid homeostasis","volume":"13","author":"Grimm","year":"2007","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.bj.2018.03.004_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0891-5849(00)00458-5","article-title":"Amyloid-\u03b2 is an antioxidant for lipoproteins in cerebrospinal fluid and plasma","volume":"30","author":"Kontush","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.bj.2018.03.004_bib22","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1073\/pnas.90.10.4748","article-title":"Amyloid beta-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth","volume":"90","author":"Koo","year":"1993","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bj.2018.03.004_bib23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3233\/JAD-2010-1230","article-title":"A physiological role for amyloid-\u03b2 protein: enhancement of learning and memory","volume":"19","author":"Morley","year":"2010","journal-title":"J Alzheim Dis"},{"key":"10.1016\/j.bj.2018.03.004_bib24","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1242\/dev.108712","article-title":"Amyloid precursor protein and neural development","volume":"141","author":"Nicolas","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.bj.2018.03.004_bib25","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1091\/mbc.3.10.1141","article-title":"Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau","volume":"3","author":"Drechsel","year":"1992","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.bj.2018.03.004_bib26","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1083\/jcb.103.6.2739","article-title":"Tau protein function in living cells","volume":"103","author":"Drubin","year":"1986","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bj.2018.03.004_bib27","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1083\/jcb.143.3.777","article-title":"Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease","volume":"143","author":"Ebneth","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bj.2018.03.004_bib28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrn2967","article-title":"Amyloid-[beta] and tau\u2013a toxic pas de deux in Alzheimer's disease","volume":"12","author":"Ittner","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bj.2018.03.004_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0166-2236(00)02031-2","article-title":"Alzheimer's disease\u2013do tauists and baptists finally shake hands?","volume":"25","author":"Mudher","year":"2002","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.bj.2018.03.004_bib31","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer's disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bj.2018.03.004_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","article-title":"Tau protein isoforms, phosphorylation and role in neurodegenerative disorders","volume":"33","author":"Bu\u00e9e","year":"2000","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.bj.2018.03.004_bib33","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0962-8924(98)01363-4","article-title":"The cell biology of \u03b2-amyloid precursor protein and presenilin in Alzheimer's disease","volume":"8","author":"Selkoe","year":"1998","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.bj.2018.03.004_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1471-4159.2011.07584.x","article-title":"Functions of A\u03b2, sAPP\u03b1 and sAPP\u03b2: similarities and differences","volume":"120","author":"Chasseigneaux","year":"2012","journal-title":"J Neurochem"},{"key":"10.1016\/j.bj.2018.03.004_bib35","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1152\/physrev.1997.77.4.1081","article-title":"Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives","volume":"77","author":"Mattson","year":"1997","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bj.2018.03.004_bib36","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1523\/JNEUROSCI.5221-09.2010","article-title":"The disintegrin\/metalloproteinase ADAM10 is essential for the establishment of the brain cortex","volume":"30","author":"Jorissen","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.bj.2018.03.004_bib37","series-title":"The non-amyloidogenic pathway: structure and function of \u03b1-secretases","first-page":"105","author":"Kojro","year":"2005"},{"key":"10.1016\/j.bj.2018.03.004_bib38","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"\u03b2-secretase cleavage of Alzheimer9s amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"Vassar","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bj.2018.03.004_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mppsy.2007.11.009","article-title":"The molecular pathology of Alzheimer's disease","volume":"7","author":"Yates","year":"2008","journal-title":"Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib40","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1021\/ja044531p","article-title":"Amyloid \u03b2-protein: monomer structure and early aggregation states of A\u03b242 and its Pro19 alloform","volume":"127","author":"Bernstein","year":"2005","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bj.2018.03.004_bib41","doi-asserted-by":"crossref","first-page":"35069","DOI":"10.1074\/jbc.M505763200","article-title":"Sequence determinants of enhanced amyloidogenicity of Alzheimer A\u03b242 peptide relative to A\u03b240","volume":"280","author":"Kim","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bj.2018.03.004_bib42","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/1071576021000049890","article-title":"Amyloid \u03b2-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review","volume":"36","author":"Allan Butterfield","year":"2002","journal-title":"Free Radic Res"},{"key":"10.1016\/j.bj.2018.03.004_bib43","doi-asserted-by":"crossref","first-page":"28176","DOI":"10.1074\/jbc.M803159200","article-title":"The ratio of monomeric to aggregated forms of A\u03b240 and A\u03b242 is an important determinant of amyloid-\u03b2 aggregation, fibrillogenesis, and toxicity","volume":"283","author":"Jan","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bj.2018.03.004_bib44","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1749-6632.1999.tb07845.x","article-title":"Neurotoxicity and oxidative damage of beta amyloid 1\u201342 versus beta amyloid 1\u201340 in the mouse cerebral cortex","volume":"893","author":"Klein","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bj.2018.03.004_bib45","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1038\/emboj.2010.211","article-title":"Neurotoxicity of Alzheimer9s disease A\u03b2 peptides is induced by small changes in the A\u03b2 42 to A\u03b2 40 ratio","volume":"29","author":"Kuperstein","year":"2010","journal-title":"EMBO J"},{"key":"10.1016\/j.bj.2018.03.004_bib46","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1523\/JNEUROSCI.12-02-00376.1992","article-title":"beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity","volume":"12","author":"Mattson","year":"1992","journal-title":"J Neurosci"},{"key":"10.1016\/j.bj.2018.03.004_bib47","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1471-2377-10-108","article-title":"Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study","volume":"10","author":"Bermejo-Pareja","year":"2010","journal-title":"BMC Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib48","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archneur.56.6.673","article-title":"Cerebrospinal fluid \u03b2-amyloid (1-42) in Alzheimer disease: differences between early-and late-onset Alzheimer disease and stability during the course of disease","volume":"56","author":"Andreasen","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib49","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.biopsych.2009.01.027","article-title":"Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid","volume":"65","author":"Grimmer","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib50","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.289.16.2094","article-title":"Decreased \u03b2-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease","volume":"289","author":"Sunderland","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.bj.2018.03.004_bib51","article-title":"Antibody-based magnetic nanoparticle immunoassay for quantification of Alzheimer's disease pathogenic factor","volume":"19","author":"Kim","year":"2014","journal-title":"J Biomed Optic"},{"key":"10.1016\/j.bj.2018.03.004_bib52","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3233\/JAD-160748","article-title":"A method for diagnosing Alzheimer's disease based on salivary amyloid-\u03b2 protein 42 levels","volume":"55","author":"Lee","year":"2017","journal-title":"J Alzheim Dis"},{"key":"10.1016\/j.bj.2018.03.004_bib53","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson's disease dementia: convergence of [alpha]-synuclein, tau and amyloid-[beta] pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bj.2018.03.004_bib54","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/mds.26191","article-title":"Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review","volume":"30","author":"Petrou","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.bj.2018.03.004_bib55","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00401-013-1121-x","article-title":"Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease","volume":"126","author":"Zhang","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.bj.2018.03.004_bib56","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","article-title":"Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective","volume":"120","author":"Tanzi","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bj.2018.03.004_bib57","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1093\/hmg\/ddp323","article-title":"Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate \u03b1-secretase activity","volume":"18","author":"Kim","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bj.2018.03.004_bib58","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein E allele \u03b54 with late-onset familial and sporadic Alzheimer's disease","volume":"43","author":"Saunders","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.bj.2018.03.004_bib59","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.neuron.2013.08.035","article-title":"ADAM10 missense mutations potentiate \u03b2-amyloid accumulation by impairing prodomain chaperone function","volume":"80","author":"Suh","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.bj.2018.03.004_bib60","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1042\/bj3230577","article-title":"Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration","volume":"323","author":"Billingsley","year":"1997","journal-title":"Biochem J"},{"key":"10.1016\/j.bj.2018.03.004_bib61","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbadis.2004.06.015","article-title":"Transcriptional and conformational changes of the tau molecule in Alzheimer's disease","volume":"1739","author":"Hyman","year":"2005","journal-title":"Biochim Biophys Acta (BBA) Mol Basis Dis"},{"key":"10.1016\/j.bj.2018.03.004_bib62","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.neurobiolaging.2009.06.005","article-title":"Endogenous A\u03b2 causes cell death via early tau hyperphosphorylation","volume":"32","author":"Amadoro","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bj.2018.03.004_bib63","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2013.10","article-title":"Cerebrospinal fluid biomarkers in Parkinson disease","volume":"9","author":"Parnetti","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1592\/phco.20.1.1.34664","article-title":"Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease","volume":"20","author":"Jann","year":"2000","journal-title":"Pharmacother: J Hum Pharmacol Drug Ther"},{"key":"10.1016\/j.bj.2018.03.004_bib65","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0924-977X(97)00079-5","article-title":"Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study","volume":"8","author":"Rogers","year":"1998","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bj.2018.03.004_bib66","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.410100203","article-title":"Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis","volume":"10","author":"Whitehouse","year":"1981","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2011.00022","article-title":"Revisiting the role of acetylcholinesterase in Alzheimer's disease: cross-talk with P-tau and \u03b2-amyloid","volume":"4","author":"Garc\u00eda-Ayll\u00f3n","year":"2011","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.bj.2018.03.004_bib68","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0896-6273(00)80108-7","article-title":"Acetylcholinesterase accelerates assembly of amyloid-\u03b2-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme","volume":"16","author":"Inestrosa","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.bj.2018.03.004_bib69","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0197-4580(02)00230-0","article-title":"Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex","volume":"24","author":"Rees","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bj.2018.03.004_bib70","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/jnnp.74.1.113","article-title":"Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease","volume":"74","author":"Rinne","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib71","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/1531-8249(200008)48:2<194::AID-ANA9>3.0.CO;2-X","article-title":"Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: a positron emission tomography study","volume":"48","author":"Shinotoh","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib72","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.clinbiochem.2003.10.007","article-title":"Association of a salivary acetylcholinesterase with Alzheimer's disease and response to cholinesterase inhibitors","volume":"37","author":"Sayer","year":"2004","journal-title":"Clin Biochem"},{"key":"10.1016\/j.bj.2018.03.004_bib73","first-page":"ZC58","article-title":"Can salivary acetylcholinesterase be a diagnostic biomarker for alzheimer?","volume":"11","author":"Bakhtiari","year":"2017","journal-title":"J Clin Diagn Res: JCDR"},{"key":"10.1016\/j.bj.2018.03.004_bib74","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/gps.1882","article-title":"Developing a simple laboratory test for Alzheimer's disease: measuring acetylcholinesterase in saliva-a pilot study","volume":"23","author":"Boston","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib75","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1017\/S0317167100029863","article-title":"Immune system response in Alzheimer's disease","volume":"16","author":"McGeer","year":"1989","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.bj.2018.03.004_bib76","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0197-4580(88)80079-4","article-title":"Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease","volume":"9","author":"Rogers","year":"1988","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bj.2018.03.004_bib77","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.dadm.2017.04.002","article-title":"Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin","volume":"8","author":"Carro","year":"2017","journal-title":"Alzheimer's Dement: Diagnosis Assess Dis Monit"},{"key":"10.1016\/j.bj.2018.03.004_bib78","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.antiviral.2004.05.002","article-title":"Inhibition of cytomegalovirus infection by lactoferrin in\u00a0vitro and in\u00a0vivo","volume":"63","author":"Beljaars","year":"2004","journal-title":"Antivir Res"},{"key":"10.1016\/j.bj.2018.03.004_bib79","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1139\/o06-039","article-title":"Lactoferrin downregulates pro-inflammatory cytokines upexpressed in intestinal epithelial cells infected with invasive or noninvasive Escherichia coli strains","volume":"84","author":"Berlutti","year":"2006","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.bj.2018.03.004_bib80","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1007\/s00018-005-5373-z","article-title":"Lactoferricin","volume":"62","author":"Gifford","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bj.2018.03.004_bib81","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.neures.2007.06.1250","article-title":"Cerebral clearance of human amyloid-\u03b2 peptide (1\u201340) across the blood-brain barrier is reduced by complex formation of activated \u03b12-macroglobulin","volume":"58","author":"Ito","year":"2007","journal-title":"Neurosci Res"},{"key":"10.1016\/j.bj.2018.03.004_bib82","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/B:BIOM.0000027691.86757.e2","article-title":"The antimicrobial activity of lactoferrin: current status and perspectives","volume":"17","author":"Orsi","year":"2004","journal-title":"Biometals"},{"key":"10.1016\/j.bj.2018.03.004_bib83","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/156720508783884675","article-title":"Functional role of lipoprotein receptors in Alzheimer's disease","volume":"5","author":"Pietrzik","year":"2008","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.bj.2018.03.004_bib84","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1046\/j.1471-4159.1999.0731393.x","article-title":"\u03b12-Macroglobulin enhances the clearance of endogenous soluble \u03b2-amyloid peptide via low-density lipoprotein receptor-related protein in cortical neuron","volume":"73","author":"Qiu","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.bj.2018.03.004_bib85","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1177\/039463201102400423","article-title":"Lactoferrin decreases inflammatory response by cystic fibrosis bronchial cells invaded with Burkholderia cenocepacia iron-modulated biofilm","volume":"24","author":"Valenti","year":"2011","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.bj.2018.03.004_bib86","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0166-3542(01)00195-4","article-title":"Antiviral activities of lactoferrin","volume":"52","author":"Van der Strate","year":"2001","journal-title":"Antivir Res"},{"key":"10.1016\/j.bj.2018.03.004_bib87","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neulet.2010.06.079","article-title":"Deposition of lactoferrin in fibrillar-type senile plaques in the brains of transgenic mouse models of Alzheimer's disease","volume":"481","author":"Wang","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bj.2018.03.004_bib88","first-page":"127","article-title":"Pathogenic microbes, the microbiome, and Alzheimer's disease (AD)","volume":"6","author":"Hill","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.bj.2018.03.004_bib89","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","article-title":"Systemic inflammation and disease progression in Alzheimer disease","volume":"73","author":"Holmes","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.bj.2018.03.004_bib90","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/jama.2010.1553","article-title":"Long-term cognitive impairment and functional disability among survivors of severe sepsis","volume":"304","author":"Iwashyna","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.bj.2018.03.004_bib91","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jalz.2007.08.004","article-title":"Inflammation and Alzheimer's disease: possible role of periodontal diseases","volume":"4","author":"Kamer","year":"2008","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.bj.2018.03.004_bib92","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","article-title":"Oxidative stress and mitochondrial dysfunction in Alzheimer's disease","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim Biophys Acta (BBA) Mol Basis Dis"},{"key":"10.1016\/j.bj.2018.03.004_bib93","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/ars.2009.2887","article-title":"Protein carbonylation","volume":"12","author":"Suzuki","year":"2010","journal-title":"Antioxidants Redox Signal"},{"key":"10.1016\/j.bj.2018.03.004_bib94","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0306-4522(00)00580-7","article-title":"Protein oxidation in the brain in Alzheimer's disease","volume":"103","author":"Aksenov","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.bj.2018.03.004_bib95","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1046\/j.1471-4159.1995.65052146.x","article-title":"Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation","volume":"65","author":"Hensley","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.bj.2018.03.004_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11357-007-9042-z","article-title":"Diurnal variations in salivary protein carbonyl levels in normal and cognitively impaired human subjects","volume":"30","author":"Su","year":"2008","journal-title":"Age"},{"key":"10.1016\/j.bj.2018.03.004_bib97","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1097\/NRL.0b013e31823966b4","article-title":"Initial motor symptoms of Parkinson disease","volume":"17","author":"Ruiz","year":"2011","journal-title":"Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib98","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib99","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008888","article-title":"Genetics of Parkinson's disease","volume":"2","author":"Klein","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.bj.2018.03.004_bib100","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1006\/enrs.2001.4264","article-title":"Environmental risk factors and Parkinson's disease: a metaanalysis","volume":"86","author":"Priyadarshi","year":"2001","journal-title":"Environ Res"},{"key":"10.1016\/j.bj.2018.03.004_bib101","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in \u03b1-synuclein mice: implications for neurodegenerative disorders","volume":"287","author":"Masliah","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bj.2018.03.004_bib102","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","article-title":"The synaptic pathology of \u03b1-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia","volume":"120","author":"Schulz-Schaeffer","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.bj.2018.03.004_bib103","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"[alpha]-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bj.2018.03.004_bib104","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jamaneurol.2013.6233","article-title":"Parkinson disease subtypes","volume":"71","author":"Thenganatt","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib105","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","article-title":"The precursor protein of non-A\u03b2 component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system","volume":"14","author":"Iwai","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.bj.2018.03.004_bib106","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"\u03b1-Synuclein promotes SNARE-complex assembly in\u00a0vivo and in\u00a0vitro","volume":"329","author":"Burr\u00e9","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bj.2018.03.004_bib107","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1074\/jbc.M112.439497","article-title":"\u03b1-Synuclein membrane association is regulated by the Rab3a recycling machinery and presynaptic activity","volume":"288","author":"Chen","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bj.2018.03.004_bib108","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","article-title":"Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal","volume":"8","author":"Maroteaux","year":"1988","journal-title":"J Neurosci"},{"key":"10.1016\/j.bj.2018.03.004_bib109","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1242\/jcs.157867","article-title":"\u03b1-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons","volume":"128","author":"Zaltieri","year":"2015","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bj.2018.03.004_bib110","doi-asserted-by":"crossref","first-page":"26292","DOI":"10.1074\/jbc.273.41.26292","article-title":"Binding of \u03b1-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation","volume":"273","author":"Jensen","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bj.2018.03.004_bib111","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1074\/jbc.M107045200","article-title":"Membrane-bound \u03b1-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form","volume":"277","author":"Lee","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bj.2018.03.004_bib112","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"\u03b1-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bj.2018.03.004_bib113","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jama.296.6.661","article-title":"Collaborative analysis of \u03b1-synuclein gene promoter variability and Parkinson disease","volume":"296","author":"Maraganore","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.bj.2018.03.004_bib114","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.20268","article-title":"\u03b1-Synuclein promoter confers susceptibility to Parkinson's disease","volume":"56","author":"Pals","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib115","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"\u03b1-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bj.2018.03.004_bib116","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1749-6632.2000.tb06903.x","article-title":"Accelerated oligomerization by Parkinson's disease linked \u03b1-synuclein mutants","volume":"920","author":"Conway","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bj.2018.03.004_bib117","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1074\/jbc.M411638200","article-title":"The E46K mutation in \u03b1-synuclein increases amyloid fibril formation","volume":"280","author":"Greenbaum","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bj.2018.03.004_bib118","doi-asserted-by":"crossref","first-page":"11604","DOI":"10.1021\/bi010616g","article-title":"Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human \u03b1-synuclein","volume":"40","author":"Li","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.bj.2018.03.004_bib119","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1074\/jbc.274.14.9843","article-title":"Both familial Parkinson's disease mutations accelerate \u03b1-synuclein aggregation","volume":"274","author":"Narhi","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bj.2018.03.004_bib120","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.expneurol.2005.10.019","article-title":"The alpha-synuclein mutation E46K promotes aggregation in cultured cells","volume":"197","author":"Pandey","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib121","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the \u03b1-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bj.2018.03.004_bib122","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cell.2005.09.028","article-title":"\u03b1-Synuclein cooperates with CSP\u03b1 in preventing neurodegeneration","volume":"123","author":"Chandra","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bj.2018.03.004_bib123","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1126\/science.1129462","article-title":"\u03b1-Synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models","volume":"313","author":"Cooper","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bj.2018.03.004_bib124","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.nbd.2004.01.001","article-title":"Abnormal \u03b1-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease","volume":"16","author":"Dalfo","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.bj.2018.03.004_bib125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/ars.2008.2247","article-title":"Oxidative stress involvement in \u00e1-synuclein oligomerization in Parkinson's disease cybrids","volume":"11","author":"Esteves","year":"2009","journal-title":"Antioxidants Redox Signal"},{"key":"10.1016\/j.bj.2018.03.004_bib126","doi-asserted-by":"crossref","first-page":"48984","DOI":"10.1074\/jbc.M208194200","article-title":"Golgi fragmentation occurs in the cells with prefibrillar \u03b1-synuclein aggregates and precedes the formation of fibrillar inclusion","volume":"277","author":"Gosavi","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bj.2018.03.004_bib127","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0002-9440(10)64553-1","article-title":"\u03b1-Synuclein promotes mitochondrial deficit and oxidative stress","volume":"157","author":"Hsu","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bj.2018.03.004_bib128","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.1090439","article-title":"Yeast cells provide insight into alpha-synuclein biology and pathobiology","volume":"302","author":"Outeiro","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bj.2018.03.004_bib129","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1093\/hmg\/ddi396","article-title":"Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity","volume":"14","author":"Smith","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bj.2018.03.004_bib130","doi-asserted-by":"crossref","first-page":"11753","DOI":"10.1074\/jbc.M208641200","article-title":"Aggregated and monomeric \u03b1-synuclein bind to the S6\u2032 proteasomal protein and inhibit proteasomal function","volume":"278","author":"Snyder","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bj.2018.03.004_bib131","first-page":"879","article-title":"Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies","volume":"152","author":"Baba","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bj.2018.03.004_bib132","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/8820","article-title":"Synphilin-1 associates with \u03b1-synuclein and promotes the formation of cytosolic inclusions","volume":"22","author":"Engelender","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.bj.2018.03.004_bib133","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"\u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bj.2018.03.004_bib134","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awr015","article-title":"Salivary \u03b1-synuclein and DJ-1: potential biomarkers for Parkinson's disease","volume":"134","author":"Devic","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.bj.2018.03.004_bib135","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4103\/1947-2714.147980","article-title":"Saliva \u03b1-synuclein and a high extinction coefficient protein: a novel approach in assessment biomarkers of Parkinson's disease","volume":"6","author":"Al-Nimer","year":"2014","journal-title":"N Am J Med Sci"},{"key":"10.1016\/j.bj.2018.03.004_bib136","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151156","article-title":"Abnormal salivary total and oligomeric alpha-synuclein in Parkinson's disease","volume":"11","author":"Vivacqua","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bj.2018.03.004_bib137","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/hmg\/ddq113","article-title":"Parkinson disease protein DJ-1 converts from a zymogen to a protease by carboxyl-terminal cleavage","volume":"19","author":"Chen","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bj.2018.03.004_bib138","doi-asserted-by":"crossref","first-page":"15091","DOI":"10.1073\/pnas.0607260103","article-title":"DJ-1, a cancer-and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2","volume":"103","author":"Clements","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bj.2018.03.004_bib139","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1093\/hmg\/ddl104","article-title":"Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease","volume":"15","author":"Tang","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bj.2018.03.004_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2014.07.009","article-title":"SG2NA recruits DJ-1 and Akt into the mitochondria and membrane to protect cells from oxidative damage","volume":"75","author":"Tanti","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.bj.2018.03.004_bib141","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1172\/JCI37617","article-title":"Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation","volume":"119","author":"Xiong","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bj.2018.03.004_bib142","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/jnr.21831","article-title":"Mitochondrial localization of DJ-1 leads to enhanced neuroprotection","volume":"87","author":"Junn","year":"2009","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.bj.2018.03.004_bib143","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/10715760500456847","article-title":"DJ-1 interacts with HIPK1 and affects H2O2-induced cell death","volume":"40","author":"Sekito","year":"2006","journal-title":"Free Radic Res"},{"key":"10.1016\/j.bj.2018.03.004_bib144","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1093\/hmg\/ddt332","article-title":"DJ-1 associates with lipid rafts by palmitoylation and regulates lipid rafts-dependent endocytosis in astrocytes","volume":"22","author":"Kim","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bj.2018.03.004_bib145","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1096\/fj.08-125153","article-title":"Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1","volume":"23","author":"Waak","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.bj.2018.03.004_bib146","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1371\/journal.pbio.0020362","article-title":"DJ-1 is a redox-dependent molecular chaperone that inhibits \u03b1-synuclein aggregate formation","volume":"2","author":"Shendelman","year":"2004","journal-title":"PLoS Biol"},{"key":"10.1016\/j.bj.2018.03.004_bib147","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fnagi.2014.00102","article-title":"Salivary DJ-1 could be an indicator of Parkinson's disease progression","volume":"6","author":"Kang","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.bj.2018.03.004_bib148","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.parkreldis.2015.07.021","article-title":"Elevated salivary protein in Parkinson's disease and salivary DJ-1 as a potential marker of disease severity","volume":"21","author":"Masters","year":"2015","journal-title":"Park Relat Disord"},{"key":"10.1016\/j.bj.2018.03.004_bib149","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/jcbfm.2012.60","article-title":"Heterogeneity of cholinergic denervation in Parkinson's disease without dementia","volume":"32","author":"Bohnen","year":"2012","journal-title":"J Cerebr Blood Flow Metab"},{"key":"10.1016\/j.bj.2018.03.004_bib150","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ana.410400309","article-title":"In\u00a0vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease","volume":"40","author":"Kuhl","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib151","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11910-013-0377-9","article-title":"Cholinergic dysfunction in Parkinson's disease","volume":"13","author":"M\u00fcller","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.bj.2018.03.004_bib152","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1212\/WNL.0b013e3182a9f558","article-title":"Gait speed in Parkinson disease correlates with cholinergic degeneration","volume":"81","author":"Bohnen","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.bj.2018.03.004_bib153","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1474-4422(16)00003-X","article-title":"Acetylcholinesterase inhibitors and gait: a steadying hand?","volume":"15","author":"Moreau","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib154","article-title":"Salivary acetylcholinesterase activity is increased in Parkinson's disease: a potential marker of parasympathetic dysfunction","volume":"2015","author":"Fedorova","year":"2015","journal-title":"Parkinson's Dis"},{"key":"10.1016\/j.bj.2018.03.004_bib155","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/306234a0","article-title":"A polymorphic DNA marker genetically linked to Huntington's disease","volume":"306","author":"Gusella","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.bj.2018.03.004_bib156","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bj.2018.03.004_bib157","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib158","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","article-title":"Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data","volume":"8","author":"Tabrizi","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib159","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The biology of huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.bj.2018.03.004_bib160","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.15252\/embj.201490808","article-title":"Huntingtin proteolysis releases non-polyQ fragments that cause toxicity through dynamin 1 dysregulation","volume":"34","author":"El-Daher","year":"2015","journal-title":"EMBO J"},{"key":"10.1016\/j.bj.2018.03.004_bib161","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bj.2018.03.004_bib162","doi-asserted-by":"crossref","first-page":"10541","DOI":"10.1523\/JNEUROSCI.0146-10.2010","article-title":"Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis","volume":"30","author":"Miller","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.bj.2018.03.004_bib163","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bj.2018.03.004_bib164","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ana.410420411","article-title":"Huntingtin localization in brains of normal and Huntington's disease patients","volume":"42","author":"Sapp","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2091-14-34","article-title":"Development of an ELISA assay for the quantification of soluble huntingtin in human blood cells","volume":"14","author":"Massai","year":"2013","journal-title":"BMC Biochem"},{"key":"10.1016\/j.bj.2018.03.004_bib166","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1172\/JCI64565","article-title":"Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression","volume":"122","author":"Weiss","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bj.2018.03.004_bib167","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1172\/JCI80743","article-title":"Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients","volume":"125","author":"Wild","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bj.2018.03.004_bib168","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.86.16_supplement.P1.053","article-title":"Salivary huntington protein as a peripheral biomarker for Huntington's disease (P1.053)","volume":"86","author":"Corey-Bloom","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.bj.2018.03.004_bib169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6508a1","article-title":"Prevalence of amyotrophic lateral sclerosis\u2014United States, 2012\u20132013","volume":"65","author":"Mehta","year":"2016","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.bj.2018.03.004_bib170","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/01.WNL.0000055861.95202.8D","article-title":"Are amyotrophic lateral sclerosis patients cognitively normal?","volume":"60","author":"Lomen-Hoerth","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bj.2018.03.004_bib171","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S1474-4422(07)70265-X","article-title":"Cognitive impairment in amyotrophic lateral sclerosis","volume":"6","author":"Phukan","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib172","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler Other Mot Neuron Disord"},{"key":"10.1016\/j.bj.2018.03.004_bib173","first-page":"1165","article-title":"A specific superoxide dismutase mutation is on the same genetic background in sporadic and familial cases of amyotrophic lateral sclerosis","volume":"59","author":"Hayward","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bj.2018.03.004_bib174","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1007\/s00415-015-7739-y","article-title":"TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations","volume":"262","author":"Pensato","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib175","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ncl.2015.07.012","article-title":"Neuropathology of amyotrophic lateral sclerosis and its variants","volume":"33","author":"Saberi","year":"2015","journal-title":"Neurol Clin"},{"key":"10.1016\/j.bj.2018.03.004_bib176","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.bj.2018.03.004_bib177","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.clineuro.2011.11.026","article-title":"Factors affecting the diagnostic delay in amyotrophic lateral sclerosis","volume":"114","author":"Cellura","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.bj.2018.03.004_bib178","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/21678421.2014.903974","article-title":"Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS)","volume":"15","author":"Paganoni","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.bj.2018.03.004_bib179","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1471-2377-13-160","article-title":"Diagnosis pathway for patients with amyotrophic lateral sclerosis: retrospective analysis of the US Medicare longitudinal claims database","volume":"13","author":"Williams","year":"2013","journal-title":"BMC Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib180","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archneur.55.4.526","article-title":"An analysis of extended survival in patients with amyotrophic lateral sclerosis treated with riluzole","volume":"55","author":"Riviere","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib181","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/07434618912331274996","article-title":"Early intervention in amyotrophic lateral sclerosis: a case presentation","volume":"5","author":"Yorkston","year":"1989","journal-title":"Augment Altern Commun"},{"key":"10.1016\/j.bj.2018.03.004_bib182","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMra021405","article-title":"The chromogranin\u2013secretogranin family","volume":"348","author":"Taupenot","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bj.2018.03.004_bib183","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1471-4159.2010.06979.x","article-title":"Neuronal over-expression of chromogranin A accelerates disease onset in a mouse model of ALS","volume":"115","author":"Ezzi","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.bj.2018.03.004_bib184","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.regpep.2008.07.009","article-title":"Chromogranin peptides in amyotrophic lateral sclerosis","volume":"152","author":"Schrott-Fischer","year":"2009","journal-title":"Regul Pept"},{"key":"10.1016\/j.bj.2018.03.004_bib185","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nn1603","article-title":"Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis","volume":"9","author":"Urushitani","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.bj.2018.03.004_bib186","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.2169\/internalmedicine.47.1278","article-title":"Salivary chromogranin A: useful and quantitative biochemical marker of affective state in patients with amyotrophic lateral sclerosis","volume":"47","author":"Obayashi","year":"2008","journal-title":"Intern Med"},{"key":"10.1016\/j.bj.2018.03.004_bib187","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1177\/1352458511403794","article-title":"High nationwide prevalence of multiple sclerosis in Sweden","volume":"17","author":"Ahlgren","year":"2011","journal-title":"Multiple Scler J"},{"key":"10.1016\/j.bj.2018.03.004_bib188","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bj.2018.03.004_bib189","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/jnnp.2008.162784","article-title":"Effect of immigration on multiple sclerosis sex ratio in Canada: the Canadian collaborative study","volume":"81","author":"Orton","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib190","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1093\/brain\/aws099","article-title":"The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service","volume":"135","author":"Wallin","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.bj.2018.03.004_bib191","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","article-title":"The immunopathology of multiple sclerosis: an overview","volume":"17","author":"Lassmann","year":"2007","journal-title":"Brain Pathol"},{"key":"10.1016\/j.bj.2018.03.004_bib192","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0092-8674(00)81107-1","article-title":"Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system","volume":"85","author":"Steinman","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bj.2018.03.004_bib193","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/135245859900500307","article-title":"Sensory symptoms of multiple sclerosis: a hidden reservoir of morbidity","volume":"5","author":"Rae-Grant","year":"1999","journal-title":"Multiple Scler J"},{"key":"10.1016\/j.bj.2018.03.004_bib194","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/jnnp.56.3.245","article-title":"Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis","volume":"56","author":"Betts","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib195","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archneur.1988.00520280085020","article-title":"Fatigue in multiple sclerosis","volume":"45","author":"Krupp","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib196","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1191\/1352458504ms1085oa","article-title":"Prevalence and treatment of spasticity reported by multiple sclerosis patients","volume":"10","author":"Rizzo","year":"2004","journal-title":"Multiple Scler J"},{"key":"10.1016\/j.bj.2018.03.004_bib197","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pmr.2013.07.002","article-title":"Gait impairment and optimizing mobility in multiple sclerosis","volume":"24","author":"Stevens","year":"2013","journal-title":"Phys Med Rehabil Clin"},{"key":"10.1016\/j.bj.2018.03.004_bib198","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","article-title":"Cognitive impairment in multiple sclerosis","volume":"7","author":"Chiaravalloti","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib199","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1176\/appi.ajp.159.11.1862","article-title":"Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample","volume":"159","author":"Chwastiak","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib200","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1212\/WNL.41.8.1193","article-title":"Cause of death in patients attending multiple sclerosis clinics","volume":"41","author":"Sadovnick","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.bj.2018.03.004_bib201","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/jnnp.55.7.542","article-title":"Suicide and multiple sclerosis: an epidemiological investigation","volume":"55","author":"Stenager","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib202","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/1352458508096878","article-title":"Differential diagnosis of suspected multiple sclerosis: a consensus approach","volume":"14","author":"Miller","year":"2008","journal-title":"Multiple Scler J"},{"key":"10.1016\/j.bj.2018.03.004_bib203","series-title":"The major histocompatibility complex and its functionshttps. Immunobiology: the immune system in health and disease","author":"Janeway","year":"2001"},{"key":"10.1016\/j.bj.2018.03.004_bib204","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bbadis.2010.07.008","article-title":"The role of antigen presenting cells in multiple sclerosis","volume":"1812","author":"Chastain","year":"2011","journal-title":"Biochim Biophys Acta (BBA) Mol Basis Dis"},{"key":"10.1016\/j.bj.2018.03.004_bib205","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fimmu.2015.00322","article-title":"Antigen presentation, autoantigens, and immune regulation in multiple sclerosis and other autoimmune diseases","volume":"6","author":"Riedhammer","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.bj.2018.03.004_bib206","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/400_2009_22","article-title":"Antigen processing and presentation in multiple sclerosis","volume":"51","author":"Stoeckle","year":"2010","journal-title":"Results Probl Cell Differ"},{"key":"10.1016\/j.bj.2018.03.004_bib207","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1212\/WNL.43.1_Part_1.163","article-title":"Multiple sclerosis is associated with genes within or close to the HLA-DR-DQ subregion on a normal DR15, DQ6, Dw2 haplotype","volume":"43","author":"Hillert","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.bj.2018.03.004_bib208","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1084\/jem.173.1.19","article-title":"A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis","volume":"173","author":"Martin","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.bj.2018.03.004_bib209","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/380997","article-title":"Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans","volume":"74","author":"Oksenberg","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bj.2018.03.004_bib210","first-page":"301","article-title":"Soluble HLA class I and class II antigens in patients with multiple sclerosis","volume":"51","author":"Ott","year":"1998","journal-title":"HLA"},{"key":"10.1016\/j.bj.2018.03.004_bib211","first-page":"1","article-title":"HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation","volume":"38","author":"Olerup","year":"1991","journal-title":"HLA"},{"key":"10.1016\/j.bj.2018.03.004_bib212","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00296-005-0585-y","article-title":"Patterns of expression in normal subjects, autoimmune diseases, and transplant recipients","volume":"25","author":"Adamashvili","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.bj.2018.03.004_bib213","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.170.3958.636","article-title":"Soluble HL-A7 antigen: localization in the \u03b2-lipoprotein fraction of human serum","volume":"170","author":"Charlton","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.bj.2018.03.004_bib214","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0167-5699(87)90170-8","article-title":"Soluble class I antigens: a conundrum with no solution?","volume":"8","author":"G\u00fcssow","year":"1987","journal-title":"Immunol today"},{"key":"10.1016\/j.bj.2018.03.004_bib215","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0198-8859(02)00450-0","article-title":"Human liver allograft acceptance and the \u201ctolerance assay\u201d: II. donor HLA-A,-B but not DR antigens are able to trigger regulation of DTH","volume":"63","author":"Jankowska-Gan","year":"2002","journal-title":"Hum Immunol"},{"key":"10.1016\/j.bj.2018.03.004_bib216","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1742-2094-2-13","article-title":"Soluble HLA measurement in saliva and cerebrospinal fluid in Caucasian patients with multiple sclerosis: a preliminary study","volume":"2","author":"Adamashvili","year":"2005","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.bj.2018.03.004_bib217","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-2094-4-16","article-title":"Saliva soluble HLA as a potential marker of response to interferon-\u03b21a in multiple sclerosis: a preliminary study","volume":"4","author":"Minagar","year":"2007","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.bj.2018.03.004_bib218","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/B978-0-12-642760-8.50008-9","article-title":"Hydroperoxides and thiol oxidants in the study of oxidative stress in intact cells and organs","author":"Sies","year":"1985","journal-title":"Oxid Stress"},{"key":"10.1016\/j.bj.2018.03.004_bib219","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbadis.2010.06.011","article-title":"Radical changes in multiple sclerosis pathogenesis","volume":"1812","author":"Van Horssen","year":"2011","journal-title":"Biochim Biophys Acta (BBA) Mol Basis Dis"},{"key":"10.1016\/j.bj.2018.03.004_bib220","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/708659","article-title":"Immunology and oxidative stress in multiple sclerosis: clinical and basic approach","volume":"2013","author":"Ortiz","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.bj.2018.03.004_bib221","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000363515","article-title":"Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis","volume":"72","author":"Wang","year":"2014","journal-title":"Eur Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib222","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clinbiochem.2014.09.023","article-title":"Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis","volume":"48","author":"Karl\u00edk","year":"2015","journal-title":"Clin Biochem"},{"key":"10.1016\/j.bj.2018.03.004_bib223","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1093\/clinchem\/38.12.2449","article-title":"Studies of lipid peroxidation products in cerebrospinal fluid and serum in multiple sclerosis and other conditions","volume":"38","author":"Naidoo","year":"1992","journal-title":"Clin Chem"},{"key":"10.1016\/j.bj.2018.03.004_bib224","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/00207451003695690","article-title":"Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain\u2013Barre syndrome and multiple sclerosis patients","volume":"120","author":"Ghabaee","year":"2010","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.bj.2018.03.004_bib225","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/BF00988606","article-title":"Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients","volume":"10","author":"Hunter","year":"1985","journal-title":"Neurochem Res"},{"key":"10.1016\/j.bj.2018.03.004_bib226","series-title":"Diagnostic and statistical manual of mental disorders-DSM-5","author":"Association","year":"2013"},{"key":"10.1016\/j.bj.2018.03.004_bib227","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S0033291700028099","article-title":"Autism as a strongly genetic disorder: evidence from a British twin study","volume":"25","author":"Bailey","year":"1995","journal-title":"Psychol Med"},{"key":"10.1016\/j.bj.2018.03.004_bib228","doi-asserted-by":"crossref","first-page":"R24","DOI":"10.1093\/hmg\/ddv273","article-title":"Genetics and genomics of autism spectrum disorder: embracing complexity","volume":"24","author":"De Rubeis","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bj.2018.03.004_bib229","doi-asserted-by":"crossref","first-page":"D1016","DOI":"10.1093\/nar\/gkr1145","article-title":"AutismKB: an evidence-based knowledgebase of autism genetics","volume":"40","author":"Xu","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bj.2018.03.004_bib230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2047-9158-2-17","article-title":"Evidence of neurodegeneration in autism spectrum disorder","volume":"2","author":"Kern","year":"2013","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.bj.2018.03.004_bib231","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/02646830500381930","article-title":"Immunity, neuroglia and neuroinflammation in autism","volume":"17","author":"Pardo","year":"2005","journal-title":"Int Rev Psychiatr"},{"key":"10.1016\/j.bj.2018.03.004_bib232","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1017\/S0954579402003115","article-title":"The neurobiological basis of autism from a developmental perspective","volume":"14","author":"Akshoomoff","year":"2002","journal-title":"Dev Psychopathol"},{"key":"10.1016\/j.bj.2018.03.004_bib233","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tins.2007.12.005","article-title":"Neuroanatomy of autism","volume":"31","author":"Amaral","year":"2008","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.bj.2018.03.004_bib234","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuroscience.2015.11.010","article-title":"The serotonin system in autism spectrum disorder: from biomarker to animal models","volume":"321","author":"Muller","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.bj.2018.03.004_bib235","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00213-013-3290-7","article-title":"Biomarkers in autism spectrum disorder: the old and the new","volume":"231","author":"Ruggeri","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bj.2018.03.004_bib236","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1542\/peds.2014-3667D","article-title":"Early screening of autism spectrum disorder: recommendations for practice and research","volume":"136","author":"Zwaigenbaum","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.bj.2018.03.004_bib237","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1542\/peds.2014-3667C","article-title":"Early identification of autism spectrum disorder: recommendations for practice and research","volume":"136","author":"Zwaigenbaum","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.bj.2018.03.004_bib238","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1017\/S0954579402002031","article-title":"Early recognition of 1-year-old infants with autism spectrum disorder versus\u00a0mental retardation","volume":"14","author":"Osterling","year":"2002","journal-title":"Dev Psychopathol"},{"key":"10.1016\/j.bj.2018.03.004_bib239","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.rasd.2011.09.002","article-title":"Outcome for children with autism receiving early and intensive behavioral intervention in mainstream preschool and kindergarten settings","volume":"6","author":"Eikeseth","year":"2012","journal-title":"Res Autism Spectr Disord"},{"key":"10.1016\/j.bj.2018.03.004_bib240","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12017-013-8222-5","article-title":"Epigenetic factors and autism spectrum disorders","volume":"15","author":"Flashner","year":"2013","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.bj.2018.03.004_bib241","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fpsyt.2012.00039","article-title":"The emerging role of microRNAs in schizophrenia and autism spectrum disorders","volume":"3","author":"Mellios","year":"2012","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib242","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1517\/14728214.2010.487860","article-title":"Emerging drugs for the treatment of symptoms associated with autism spectrum disorders","volume":"15","author":"Wink","year":"2010","journal-title":"Expet Opin Emerg Drugs"},{"key":"10.1016\/j.bj.2018.03.004_bib243","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12887-016-0586-x","article-title":"Salivary miRNA profiles identify children with autism spectrum disorder, correlate with adaptive behavior, and implicate ASD candidate genes involved in neurodevelopment","volume":"16","author":"Hicks","year":"2016","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.bj.2018.03.004_bib244","series-title":"Vineland adaptive behavior scales","author":"Sparrow","year":"1984"},{"key":"10.1016\/j.bj.2018.03.004_bib245","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbi.2010.08.003","article-title":"Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome","volume":"25","author":"Ashwood","year":"2011","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.bj.2018.03.004_bib246","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrn3978","article-title":"Immune mediators in the brain and peripheral tissues in autism spectrum disorder","volume":"16","author":"Estes","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bj.2018.03.004_bib247","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fpsyt.2015.00121","article-title":"The impact of neuroimmune alterations in autism spectrum disorder","volume":"6","author":"Gottfried","year":"2015","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib248","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/EDE.0b013e3181f26e3f","article-title":"Parental autoimmune diseases associated with autism spectrum disorders in offspring","volume":"21","author":"Keil","year":"2010","journal-title":"Epidemiology"},{"key":"10.1016\/j.bj.2018.03.004_bib249","doi-asserted-by":"crossref","first-page":"9942","DOI":"10.3748\/wjg.v20.i29.9942","article-title":"Pathophysiology of autism spectrum disorders: revisiting gastrointestinal involvement and immune imbalance","volume":"20","author":"Samsam","year":"2014","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.bj.2018.03.004_bib250","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/aur.1450","article-title":"A pilot proteomic analysis of salivary biomarkers in autism spectrum disorder","volume":"8","author":"Wetie","year":"2015","journal-title":"Autism Res"},{"key":"10.1016\/j.bj.2018.03.004_bib251","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1021\/pr8004088","article-title":"Hypo-phosphorylation of salivary peptidome as a clue to the molecular pathogenesis of autism spectrum disorders","volume":"7","author":"Castagnola","year":"2008","journal-title":"J Proteome Res"},{"key":"10.1016\/j.bj.2018.03.004_bib252","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10673229.2011.549771","article-title":"The role of oxytocin in mother-infant relations: a systematic review of human studies","volume":"19","author":"Galbally","year":"2011","journal-title":"Harv Rev Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib253","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.yfrne.2009.05.005","article-title":"Oxytocin, vasopressin, and human social behavior","volume":"30","author":"Heinrichs","year":"2009","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.bj.2018.03.004_bib254","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuron.2012.09.025","article-title":"Neuromodulation by oxytocin and vasopressin","volume":"76","author":"Stoop","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.bj.2018.03.004_bib255","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.biopsych.2009.09.020","article-title":"Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders","volume":"67","author":"Guastella","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib256","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.biopsych.2006.05.030","article-title":"Oxytocin increases retention of social cognition in autism","volume":"61","author":"Hollander","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib257","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.npp.1300021","article-title":"Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders","volume":"28","author":"Hollander","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bj.2018.03.004_bib258","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.biopsych.2007.11.015","article-title":"Genes controlling affiliative behavior as candidate genes for autism","volume":"63","author":"Yrigollen","year":"2008","journal-title":"Biol Psychiatr"},{"key":"10.1016\/j.bj.2018.03.004_bib259","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1192\/bjp.bp.113.137513","article-title":"Parent-child interaction and oxytocin production in pre-schoolers with autism spectrum disorder","volume":"205","author":"Feldman","year":"2014","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib260","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fnins.2014.00295","article-title":"Visual attention for social information and salivary oxytocin levels in preschool children with autism spectrum disorders: an eye-tracking study","volume":"8","author":"Fujisawa","year":"2014","journal-title":"Front Neurosci"},{"key":"10.1016\/j.bj.2018.03.004_bib261","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.psychres.2016.04.117","article-title":"Peripheral oxytocin and vasopressin: biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis","volume":"241","author":"Rutigliano","year":"2016","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bj.2018.03.004_bib262","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/bmj.280.6207.66","article-title":"Molecular pathology of schizophrenia: more than one disease process?","volume":"280","author":"Crow","year":"1980","journal-title":"Br Med J"},{"key":"10.1016\/j.bj.2018.03.004_bib263","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/schbul\/17.3.515","article-title":"Examining the underlying structure of schizophrenic phenomenology: evidence for a three-process model","volume":"17","author":"Lenzenweger","year":"1991","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.bj.2018.03.004_bib264","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/schbul\/1.11.61","article-title":"Speculations on the processes that underlie schizophrenic symptoms and signs: III","volume":"1","author":"Strauss","year":"1974","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.bj.2018.03.004_bib265","series-title":"Abnormal psychology","author":"Kring","year":"2015"},{"key":"10.1016\/j.bj.2018.03.004_bib266","doi-asserted-by":"crossref","first-page":"693","DOI":"10.4088\/JCP.v66n0604","article-title":"Suicide and attempted suicide in bipolar disorder: a systematic review of risk factors","volume":"66","author":"Hawton","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib267","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/1359786810385490","article-title":"Suicide and schizophrenia: a systematic review of rates and risk factors","volume":"24","author":"Hor","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.bj.2018.03.004_bib268","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(12)62129-1","article-title":"Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis","volume":"381","author":"Consortium C-DGotPG","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.bj.2018.03.004_bib269","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nature08185","article-title":"Common polygenic variation contributes to risk of schizophrenia that overlaps with bipolar disorder","volume":"460","author":"Consortium IS","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bj.2018.03.004_bib270","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/ng.940","article-title":"Genome-wide association study identifies five new schizophrenia loci","volume":"43","author":"Consortium SPG-WAS","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.bj.2018.03.004_bib271","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/ng.943","article-title":"Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4","volume":"43","author":"Group PGCBDW","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.bj.2018.03.004_bib272","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/ajmg.b.30867","article-title":"Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations","volume":"147","author":"Lasky-Su","year":"2008","journal-title":"Am J Med Genet Part B: Neuropsychiatric Genet"},{"key":"10.1016\/j.bj.2018.03.004_bib273","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jmg.2005.030718","article-title":"The genetics of schizophrenia and bipolar disorder: dissecting psychosis","volume":"42","author":"Craddock","year":"2005","journal-title":"J Med Genet"},{"key":"10.1016\/j.bj.2018.03.004_bib274","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1093\/hmg\/ddr416","article-title":"Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder","volume":"20","author":"Dempster","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bj.2018.03.004_bib275","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.neuropharm.2010.10.021","article-title":"Epigenetic GABAergic targets in schizophrenia and bipolar disorder","volume":"60","author":"Guidotti","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bj.2018.03.004_bib276","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1469-7610.2008.01909.x","article-title":"Pre-and peri-natal environmental risks for attention-deficit hyperactivity disorder (ADHD): the potential role of epigenetic processes in mediating susceptibility","volume":"49","author":"Mill","year":"2008","journal-title":"J Child Psychol Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib277","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.biopsych.2004.02.005","article-title":"The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis","volume":"55","author":"Petronis","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib278","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1038\/tp.2012.55","article-title":"Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients","volume":"2","author":"Rao","year":"2012","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib279","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bbagen.2009.06.009","article-title":"Epigenetic mechanisms in schizophrenia","volume":"1790","author":"Roth","year":"2009","journal-title":"Biochim Biophys Acta (BBA) Gen Subj"},{"key":"10.1016\/j.bj.2018.03.004_bib280","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/ajmg.b.32361","article-title":"Antipsychotic drugs attenuate aberrant DNA methylation of DTNBP1 (dysbindin) promoter in saliva and post-mortem brain of patients with schizophrenia and Psychotic bipolar disorder","volume":"168","author":"Abdolmaleky","year":"2015","journal-title":"Am J Med Genet Part B: Neuropsychiatric Genet"},{"key":"10.1016\/j.bj.2018.03.004_bib281","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ajmg.b.31192","article-title":"Hypomethylation of the serotonin receptor type-2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder","volume":"156","author":"Ghadirivasfi","year":"2011","journal-title":"Am J Med Genet Part B: Neuropsychiatric Genet"},{"key":"10.1016\/j.bj.2018.03.004_bib282","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.jpsychires.2011.06.013","article-title":"DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder","volume":"45","author":"Nohesara","year":"2011","journal-title":"J Psychiatry Res"},{"key":"10.1016\/j.bj.2018.03.004_bib283","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/jcpp.12457","article-title":"Methylomic analysis of salivary DNA in childhood ADHD identifies altered DNA methylation in VIPR2","volume":"57","author":"Wilmot","year":"2016","journal-title":"J Child Psychol Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib284","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/schbul\/sbj033","article-title":"Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology","volume":"32","author":"Craddock","year":"2006","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.bj.2018.03.004_bib285","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.biopsych.2003.09.017","article-title":"Serotonin 5-HT 1A, 5-HT 1B, and 5-HT 2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia","volume":"55","author":"L\u00f3pez-Figueroa","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib286","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/schbul\/14.2.297","article-title":"The role of serotonin in schizophrenia","volume":"14","author":"Bleich","year":"1988","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.bj.2018.03.004_bib287","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1399-5618.2009.00760.x","article-title":"The role of dopamine in bipolar disorder","volume":"11","author":"Cousins","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.bj.2018.03.004_bib288","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","article-title":"Dopamine in schizophrenia: a review and reconceptualization","volume":"148","author":"Davis","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib289","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0327(00)00226-3","article-title":"Serotonin and bipolar disorder","volume":"66","author":"Mahmood","year":"2001","journal-title":"J Affect Disord"},{"key":"10.1016\/j.bj.2018.03.004_bib290","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s11055-010-9348-7","article-title":"Polymorphism of serotonin receptor genes (5-HTR2A) and Dysbindin (DTNBP1) and individual components of short-term verbal memory processes in schizophrenia","volume":"40","author":"Alfimova","year":"2010","journal-title":"Neurosci Behav Physiol"},{"key":"10.1016\/j.bj.2018.03.004_bib291","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.biopsych.2010.09.012","article-title":"Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance","volume":"69","author":"Karlsgodt","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib292","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.4161\/epi.29223","article-title":"MB-COMT promoter DNA methylation is associated with working-memory processing in schizophrenia patients and healthy controls","volume":"9","author":"Walton","year":"2014","journal-title":"Epigenetics"},{"key":"10.1016\/j.bj.2018.03.004_bib293","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.eurpsy.2015.01.008","article-title":"Dysbindin (DTNBP1) variants are associated with hallucinations in schizophrenia","volume":"30","author":"Cheah","year":"2015","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib294","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pnpbp.2012.06.006","article-title":"Association of MB-COMT polymorphisms with schizophrenia-susceptibility and symptom severity in an African cohort","volume":"39","author":"Wright","year":"2012","journal-title":"Prog Neuro Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib295","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.schres.2008.05.015","article-title":"Differential association of the COMT Val158Met polymorphism with clinical phenotypes in schizophrenia and bipolar disorder","volume":"103","author":"Goghari","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bj.2018.03.004_bib296","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.biopsych.2016.03.2100","article-title":"DNA methylation signatures of early childhood malnutrition associated with impairments in attention and cognition","volume":"80","author":"Peter","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib297","doi-asserted-by":"crossref","DOI":"10.1177\/1087054717696769","article-title":"Epigenetics and ADHD: Toward An integrative approach of the disorder pathogenesis","author":"Hamza","year":"2017","journal-title":"J Atten Disord"},{"key":"10.1016\/j.bj.2018.03.004_bib298","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2007.02.018","article-title":"Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder","volume":"104","author":"Kim","year":"2007","journal-title":"J Affect Disord"},{"key":"10.1016\/j.bj.2018.03.004_bib299","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1749-6632.2000.tb05410.x","article-title":"The immune system and schizophrenia: an integrative view","volume":"917","author":"M\u00fcller","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bj.2018.03.004_bib300","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1399-5618.2007.00493.x","article-title":"Immune variations in bipolar disorder: phasic differences","volume":"9","author":"Ortiz-Dom\u00ednguez","year":"2007","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.bj.2018.03.004_bib301","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaut.2006.07.006","article-title":"Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited","volume":"27","author":"Strous","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.bj.2018.03.004_bib302","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jprot.2014.03.020","article-title":"Characterization of salivary proteins of schizophrenic and bipolar disorder patients by top-down proteomics","volume":"103","author":"Iavarone","year":"2014","journal-title":"J Proteom"},{"key":"10.1016\/j.bj.2018.03.004_bib303","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1189\/jlb.0306170","article-title":"S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules","volume":"81","author":"Foell","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.bj.2018.03.004_bib304","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nri1180","article-title":"Defensins: antimicrobial peptides of innate immunity","volume":"3","author":"Ganz","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bj.2018.03.004_bib305","doi-asserted-by":"crossref","first-page":"45","DOI":"10.7150\/jca.5044","article-title":"Cystatins in immune system","volume":"4","author":"Magister","year":"2013","journal-title":"J Cancer"},{"key":"10.1016\/j.bj.2018.03.004_bib306","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00726-008-0097-7","article-title":"Human S100A12: a novel key player in inflammation?","volume":"36","author":"Pietzsch","year":"2009","journal-title":"Amino Acids"},{"key":"10.1016\/j.bj.2018.03.004_bib307","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.psychres.2010.09.012","article-title":"Oral health and the symptoms of schizophrenia","volume":"188","author":"Arnaiz","year":"2011","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bj.2018.03.004_bib308","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12903-015-0065-z","article-title":"A cross-sectional study on oral health and dental care in intellectually able adults with autism spectrum disorder","volume":"15","author":"Bejerot","year":"2015","journal-title":"BMC Oral Health"},{"key":"10.1016\/j.bj.2018.03.004_bib309","first-page":"20","article-title":"Dental care for the patient with bipolar disorder","volume":"69","author":"Clark","year":"2003","journal-title":"J Can Dent Assoc"},{"key":"10.1016\/j.bj.2018.03.004_bib310","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2174\/156720510791162359","article-title":"Oral health in Alzheimer's disease: a review","volume":"7","author":"Mancini","year":"2010","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.bj.2018.03.004_bib311","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1754-4505.2011.00205.x","article-title":"Caries and periodontal disease in patients with Parkinson's disease","volume":"31","author":"M\u00fcller","year":"2011","journal-title":"Spec Care Dent"},{"key":"10.1016\/j.bj.2018.03.004_bib312","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1471-2377-13-114","article-title":"Oral and dental health in Huntington\u2018s disease-an observational study","volume":"13","author":"Saft","year":"2013","journal-title":"BMC Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib313","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/ene.12103","article-title":"Association between multiple sclerosis and chronic periodontitis: a population-based pilot study","volume":"20","author":"Sheu","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib314","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/j.1468-1331.2010.02973.x","article-title":"Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington's disease","volume":"17","author":"Aziz","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib315","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/mds.20189","article-title":"Salivary production in Parkinson's disease","volume":"20","author":"Proulx","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.bj.2018.03.004_bib316","doi-asserted-by":"crossref","first-page":"M61","DOI":"10.1093\/geronj\/45.2.M61","article-title":"Diminished submandibular salivary flow in dementia of the Alzheimer type","volume":"45","author":"Ship","year":"1990","journal-title":"J Gerontol"},{"key":"10.1016\/j.bj.2018.03.004_bib317","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/mds.20784","article-title":"Quantitative study of salivary secretion in Parkinson's disease","volume":"21","author":"Tumilasci","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.bj.2018.03.004_bib318","article-title":"Treatment for sialorrhea (excessive saliva) in people with motor neuron disease\/amyotrophic lateral sclerosis","volume":"11","author":"Young","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bj.2018.03.004_bib319","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1176\/ajp.139.10.1350","article-title":"Sialorrhea as a side effect of lithium: a case report","volume":"139","author":"Donaldson","year":"1982","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib320","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00213-005-0248-4","article-title":"Clozapine-induced sialorrhea: pathophysiology and management strategies","volume":"185","author":"Praharaj","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bj.2018.03.004_bib321","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1113\/jphysiol.1972.sp009721","article-title":"Circadian rhythms in human salivary flow rate and composition","volume":"220","author":"Dawes","year":"1972","journal-title":"J Physiol"},{"key":"10.1016\/j.bj.2018.03.004_bib322","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1373\/clinchem.2014.230433","article-title":"The landscape of microRNA, Piwi-interacting RNA, and circular RNA in human saliva","volume":"61","author":"Bahn","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.bj.2018.03.004_bib323","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s12035-011-8211-3","article-title":"Functions of noncoding RNAs in neural development and neurological diseases","volume":"44","author":"Bian","year":"2011","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.bj.2018.03.004_bib324","doi-asserted-by":"crossref","first-page":"e7440","DOI":"10.1371\/journal.pone.0007440","article-title":"Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls","volume":"4","author":"Keller","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bj.2018.03.004_bib325","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ncomms1781","article-title":"sAPP-\u03b1 modulates \u03b2-secretase activity and amyloid-\u03b2 generation","volume":"3","author":"Obregon","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.bj.2018.03.004_bib326","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1523\/JNEUROSCI.23-13-05531.2003","article-title":"The production of amyloid \u03b2 peptide is a critical requirement for the viability of central neurons","volume":"23","author":"Plant","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.bj.2018.03.004_bib327","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tins.2003.10.008","article-title":"Living with the enemy: a physiological role for the \u03b2-amyloid peptide","volume":"27","author":"Esteban","year":"2004","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.bj.2018.03.004_bib328","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1523\/JNEUROSCI.0203-11.2011","article-title":"Soluble A\u03b2 oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors","volume":"31","author":"Li","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.bj.2018.03.004_bib329","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1326-9-48","article-title":"Oligomeric A\u03b2-induced synaptic dysfunction in Alzheimer's disease","volume":"9","author":"Tu","year":"2014","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.bj.2018.03.004_bib330","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1074\/jbc.M607483200","article-title":"A\u03b2 oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine","volume":"282","author":"De Felice","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bj.2018.03.004_bib331","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuron.2008.07.013","article-title":"Linking calcium to A\u03b2 and Alzheimer's disease","volume":"59","author":"Green","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.bj.2018.03.004_bib332","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/hmg\/ddl066","article-title":"Mitochondria are a direct site of A\u03b2 accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression","volume":"15","author":"Manczak","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bj.2018.03.004_bib333","first-page":"313","article-title":"Amyloid-beta peptide induced inflammatory reaction is mediated by the cytokines tumor necrosis factor and interleukin-1","volume":"31","author":"Sutton","year":"1999","journal-title":"J Submicr Cytol Pathol"},{"key":"10.1016\/j.bj.2018.03.004_bib334","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1471-4159.2011.07475.x","article-title":"The physiology of the \u03b2-amyloid precursor protein intracellular domain AICD","volume":"120","author":"Pardossi-Piquard","year":"2012","journal-title":"J Neurochem"},{"key":"10.1016\/j.bj.2018.03.004_bib335","doi-asserted-by":"crossref","first-page":"656","DOI":"10.5483\/BMBRep.2010.43.10.656","article-title":"Possible roles of amyloid intracellular domain of amyloid precursor protein","volume":"43","author":"Chang","year":"2010","journal-title":"BMB Rep"},{"key":"10.1016\/j.bj.2018.03.004_bib336","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00018-008-8463-x","article-title":"Prolactin inducible protein in cancer, fertility and immunoregulation: structure, function and its clinical implications","volume":"66","author":"Hassan","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bj.2018.03.004_bib337","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4049\/jimmunol.1004073","article-title":"Cleavage of annexin A1 by ADAM10 during secondary necrosis generates a monocytic \u201cfind-me\u201d signal","volume":"188","author":"Blume","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.bj.2018.03.004_bib338","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062449","article-title":"Annexin A1 on the surface of early apoptotic cells suppresses CD8+ T cell immunity","volume":"8","author":"Weyd","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bj.2018.03.004_bib339","doi-asserted-by":"crossref","first-page":"7669","DOI":"10.4049\/jimmunol.172.12.7669","article-title":"An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family","volume":"172","author":"Ernst","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.bj.2018.03.004_bib340","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1097-2765(00)80323-8","article-title":"A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR","volume":"5","author":"Walther","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.bj.2018.03.004_bib341","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri2470","article-title":"Annexin A1 and glucocorticoids as effectors of the resolution of inflammation","volume":"9","author":"Perretti","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bj.2018.03.004_bib342","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1172\/JCI65831","article-title":"Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair","volume":"123","author":"Leoni","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bj.2018.03.004_bib343","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1110\/ps.062336606","article-title":"Crystal structures of human \u03b1-defensins HNP4, HD5, and HD6","volume":"15","author":"Szyk","year":"2006","journal-title":"Protein Sci"},{"key":"10.1016\/j.bj.2018.03.004_bib344","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2183\/pjab.88.152","article-title":"Antimicrobial peptide defensin: identification of novel isoforms and the characterization of their physiological roles and their significance in the pathogenesis of diseases","volume":"88","author":"Yamaguchi","year":"2012","journal-title":"Proc Jpn Acad Ser B"},{"key":"10.1016\/j.bj.2018.03.004_bib345","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.0906-6705.2004.00145.x","article-title":"Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis","volume":"13","author":"Tralau","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.bj.2018.03.004_bib346","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1042\/bj20031790","article-title":"The periplasmic serine protease inhibitor ecotin protects bacteria against neutrophil elastase","volume":"379","author":"Eggers","year":"2004","journal-title":"Biochem J"},{"key":"10.1016\/j.bj.2018.03.004_bib347","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000857","article-title":"Proteolysis of human thrombin generates novel host defense peptides","volume":"6","author":"Papareddy","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bj.2018.03.004_bib348","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1128\/MCB.00596-09","article-title":"Contributions to neutropenia from PFAAP5 (N4BP2L2), a novel protein mediating transcriptional repressor cooperation between Gfi1 and neutrophil elastase","volume":"29","author":"Salipante","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bj.2018.03.004_bib349","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF02256548","article-title":"Neutrophil elastase induces IL-8 synthesis by lung epithelial cells via the mitogen-activated protein kinase pathway","volume":"11","author":"Chen","year":"2004","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.bj.2018.03.004_bib350","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1189\/jlb.72.3.538","article-title":"Disruption of CD40\/CD40 ligand interaction with cleavage of CD40 on human gingival fibroblasts by human leukocyte elastase resulting in down-regulation of chemokine production","volume":"72","author":"Nemoto","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.bj.2018.03.004_bib351","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1165\/rcmb.2002-0152OC","article-title":"Lactoperoxidase and human airway host defense","volume":"29","author":"Wijkstrom-Frei","year":"2003","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.bj.2018.03.004_bib352","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1039\/c3mb25463a","article-title":"Shotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma naive to therapy","volume":"9","author":"Pieragostino","year":"2013","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.bj.2018.03.004_bib353","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1074\/jbc.272.3.1837","article-title":"The salivary lipocalin von Ebner's gland protein is a cysteine proteinase inhibitor","volume":"272","author":"van't Hof","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bj.2018.03.004_bib354","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev.iy.12.040194.000431","article-title":"Transepithelial transport of immunoglobulins","volume":"12","author":"Mostov","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bj.2018.03.004_bib355","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1074-7613(00)80610-X","article-title":"Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM","volume":"9","author":"Bomsel","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.bj.2018.03.004_bib356","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1128\/jvi.69.2.1339-1343.1995","article-title":"Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies","volume":"69","author":"Mazanec","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.bj.2018.03.004_bib357","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.bjc.6690035","article-title":"Lack of DMBT1 expression in oesophageal, gastric and colon cancers","volume":"79","author":"Mori","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bj.2018.03.004_bib358","first-page":"1846","article-title":"Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer","volume":"59","author":"Wu","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.bj.2018.03.004_bib359","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/sj.onc.1202066","article-title":"Molecular analysis of two putative tumour suppressor genes, PTEN and DMBT, which have been implicated in glioblastoma multiforme disease progression","volume":"17","author":"Somerville","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.bj.2018.03.004_bib360","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1189\/jlb.0712349","article-title":"Myeloperoxidase: a front-line defender against phagocytosed microorganisms","volume":"93","author":"Klebanoff","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.bj.2018.03.004_bib361","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1182\/blood-2010-06-290171","article-title":"Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity","volume":"117","author":"Metzler","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bj.2018.03.004_bib362","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1093\/rheumatology\/kes193","article-title":"Myeloperoxidase and oxidative stress in rheumatoid arthritis","volume":"51","author":"Stamp","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.bj.2018.03.004_bib363","doi-asserted-by":"crossref","first-page":"22461","DOI":"10.1074\/jbc.M001434200","article-title":"Myeloperoxidase is involved in H2O2-induced apoptosis of HL-60 human leukemia cells","volume":"275","author":"Wagner","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bj.2018.03.004_bib364","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1182\/blood-2010-05-284513","article-title":"Myeloperoxidase attracts neutrophils by physical forces","volume":"117","author":"Klinke","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bj.2018.03.004_bib365","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1126\/science.169.3950.1095","article-title":"Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes","volume":"169","author":"Klebanoff","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.bj.2018.03.004_bib366","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1182\/blood-2012-09-456483","article-title":"Neutrophil myeloperoxidase regulates T-cell\u2212 driven tissue inflammation in mice by inhibiting dendritic cell function","volume":"121","author":"Odobasic","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bj.2018.03.004_bib367","first-page":"373","article-title":"Complete covalent structure of a proline-rich phosphoprotein, PRP-2, an inhibitor of calcium phosphate crystal growth from human parotid saliva","volume":"27","author":"Schlesinger","year":"1986","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bj.2018.03.004_bib368","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0003-9969(85)90086-X","article-title":"Inhibition of calcium-carbonate precipitation by human salivary proline-rich phosphoproteins","volume":"30","author":"Saitoh","year":"1985","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.bj.2018.03.004_bib369","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1016\/S0021-9258(19)69314-2","article-title":"The location and nature of calcium-binding sites in salivary acidic proline-rich phosphoproteins","volume":"256","author":"Bennick","year":"1981","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bj.2018.03.004_bib370","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1600-0722.2006.00328.x","article-title":"Two-dimensional electrophoresis study of in\u00a0vitro pellicle formation and dental caries susceptibility","volume":"114","author":"Vitorino","year":"2006","journal-title":"Eur J Oral Sci"},{"key":"10.1016\/j.bj.2018.03.004_bib371","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0003-9969(91)90014-L","article-title":"The effects of human salivary cystatins and statherin on hydroxyapatite crystallization","volume":"36","author":"Johnsson","year":"1991","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.bj.2018.03.004_bib372","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/iai.56.2.439-445.1988","article-title":"Human salivary acidic proline-rich proteins and statherin promote the attachment of Actinomyces viscosus LY7 to apatitic surfaces","volume":"56","author":"Gibbons","year":"1988","journal-title":"Infect Immun"},{"key":"10.1016\/j.bj.2018.03.004_bib373","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.1016\/S0021-9258(18)42650-6","article-title":"Salivary statherin. Dependence on sequence, charge, hydrogen bonding potency, and helical conformation for adsorption to hydroxyapatite and inhibition of mineralization","volume":"267","author":"Raj","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bj.2018.03.004_bib374","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0006-291X(05)81259-8","article-title":"Statherin: a major boundary lubricant of human saliva","volume":"180","author":"Douglas","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bj.2018.03.004_bib375","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1096\/fj.08-112003","article-title":"Histatins are the major wound-closure stimulating factors in human saliva as identified in a cell culture assay","volume":"22","author":"Oudhoff","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.bj.2018.03.004_bib376","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/10454411980090040601","article-title":"Human salivary histatins: promising anti-fungal therapeutic agents","volume":"9","author":"Tsai","year":"1998","journal-title":"Crit Rev Oral Biol Med"},{"key":"10.1016\/j.bj.2018.03.004_bib377","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0021-9258(17)36072-6","article-title":"The primary structure and functional characterization of the neutral histidine-rich polypeptide from human parotid secretion","volume":"261","author":"Oppenheim","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bj.2018.03.004_bib378","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/archneur.57.1.100","article-title":"Plasma and cerebrospinal fluid levels of amyloid \u03b2 proteins 1-40 and 1-42 in Alzheimer disease","volume":"57","author":"Mehta","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib379","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2174\/156720510791383796","article-title":"The cerebrospinal fluid amyloid \u03b242\/40 ratio in the differentiation of alzheimer's disease from non-alzheimer's dementia","volume":"7","author":"Spies","year":"2010","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.bj.2018.03.004_bib380","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1212\/01.WNL.0000091890.32140.8F","article-title":"Plasma A\u03b240 and A\u03b242 and Alzheimer's disease Relation to age, mortality, and risk","volume":"61","author":"Mayeux","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bj.2018.03.004_bib381","doi-asserted-by":"crossref","first-page":"14052","DOI":"10.1073\/pnas.0805902105","article-title":"Peripheral A\u03b2 subspecies as risk biomarkers of Alzheimer's disease","volume":"105","author":"Schupf","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bj.2018.03.004_bib382","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3233\/JAD-2010-090249","article-title":"Plasma amyloid-\u03b2 as a biomarker in Alzheimer's disease: the AIBL study of aging","volume":"20","author":"Lui","year":"2010","journal-title":"J Alzheim Dis"},{"key":"10.1016\/j.bj.2018.03.004_bib383","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.expneurol.2009.07.024","article-title":"Amyloid \u03b2 peptides in plasma in early diagnosis of Alzheimer's disease: a multicenter study with multiplexing","volume":"223","author":"Lewczuk","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib384","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/gps.4053","article-title":"The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease","volume":"29","author":"Wang","year":"2014","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib385","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/archneurol.2007.57","article-title":"Plasma \u03b2 amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study","volume":"65","author":"Sundel\u00f6f","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib386","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/jnnp.64.3.298","article-title":"Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study","volume":"64","author":"Andreasen","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bj.2018.03.004_bib387","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1212\/WNL.45.4.788","article-title":"Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease","volume":"45","author":"Vigo-Pelfrey","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.bj.2018.03.004_bib388","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0024-3205(96)00583-8","article-title":"Oxidative-stress associated parameters (lactoferrin, superoxide dismutases) in serum of patients with Alzheimer's disease","volume":"60","author":"Thome","year":"1996","journal-title":"Life Sci"},{"key":"10.1016\/j.bj.2018.03.004_bib389","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0024-3205(96)00349-9","article-title":"Advanced glycation endproducts\u2014associated parameters in the peripheral blood of patients with Alzheimer's disease","volume":"59","author":"Thome","year":"1996","journal-title":"Life Sci"},{"key":"10.1016\/j.bj.2018.03.004_bib390","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1097\/00001756-199512150-00017","article-title":"Increased acetylcholinesterase activity in the CSF of Alzheimer patients carrying apolipoprotein epsilon4 allele","volume":"6","author":"Soininen","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.bj.2018.03.004_bib391","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF01677425","article-title":"Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease","volume":"75","author":"Sirvi\u00f6","year":"1989","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bj.2018.03.004_bib392","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0024-3205(82)90267-3","article-title":"Cholinesterase enzymes in the blood of patients with Alzheimer's disease","volume":"30","author":"Smith","year":"1982","journal-title":"Life Sci"},{"key":"10.1016\/j.bj.2018.03.004_bib393","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1600-0404.2008.01057.x","article-title":"Cerebrospinal fluid, serum and plasma protein oxidation in Alzheimer's disease","volume":"119","author":"Korolainen","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.bj.2018.03.004_bib394","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1006\/bbrc.2000.3356","article-title":"Oxidized proteins in Alzheimer's plasma","volume":"275","author":"Conrad","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bj.2018.03.004_bib395","first-page":"441","article-title":"Carbonyl proteins as a clinical marker in Alzheimer's disease and its relation to tryptophan degradation and immune activation","volume":"56","author":"Greilberger","year":"2010","journal-title":"Clin Lab J Clin Lab Lab Relat"},{"key":"10.1016\/j.bj.2018.03.004_bib396","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/10715760802255764","article-title":"Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease","volume":"42","author":"Greilberger","year":"2008","journal-title":"Free Radic Res"},{"key":"10.1016\/j.bj.2018.03.004_bib397","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.exger.2012.05.019","article-title":"Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia","volume":"47","author":"Puertas","year":"2012","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.bj.2018.03.004_bib398","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","article-title":"DJ-1 and \u03b1-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease","volume":"133","author":"Hong","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.bj.2018.03.004_bib399","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.expneurol.2006.12.006","article-title":"Plasma \u03b1-synuclein is decreased in subjects with Parkinson's disease","volume":"204","author":"Li","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib400","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/mds.22928","article-title":"Plasma \u03b1-synuclein in patients with Parkinson's disease with and without treatment","volume":"25","author":"Duran","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.bj.2018.03.004_bib401","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00702-005-0427-9","article-title":"The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy","volume":"113","author":"Lee","year":"2006","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bj.2018.03.004_bib402","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.bbrc.2006.05.011","article-title":"Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease","volume":"345","author":"Waragai","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bj.2018.03.004_bib403","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.22311","article-title":"Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression","volume":"69","author":"Shi","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bj.2018.03.004_bib404","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neulet.2007.08.010","article-title":"Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson's disease","volume":"425","author":"Waragai","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bj.2018.03.004_bib405","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neulet.2007.11.027","article-title":"Secretion of DJ-1 into the serum of patients with Parkinson's disease","volume":"431","author":"Maita","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bj.2018.03.004_bib406","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2010.06.009","article-title":"Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease","volume":"480","author":"Shi","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bj.2018.03.004_bib407","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF01675356","article-title":"Plasma dopamine-beta-hydroxylase and erythrocyte acetylcholinesterase in a group of patients with Parkinson disease","volume":"42","author":"Coelho","year":"1978","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bj.2018.03.004_bib408","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/ane.12735","article-title":"Cerebrospinal fluid levels of chromogranin A and phosphorylated neurofilament heavy chain are elevated in amyotrophic lateral sclerosis","volume":"136","author":"Kaiserova","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.bj.2018.03.004_bib409","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0198-8859(97)00004-9","article-title":"Soluble HLA class I and class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patients","volume":"54","author":"Filaci","year":"1997","journal-title":"Hum Immunol"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417017304158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417017304158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T17:53:40Z","timestamp":1720288420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2319417017304158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":409,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S2319417017304158"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2018.03.004","relation":{},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salivary biomarkers for the diagnosis and\u00a0monitoring of neurological diseases","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2018.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Chang Gung University. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}